These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2554623)

  • 21. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines.
    Nauwynck HJ; Zonnekeyn V; Pensaert MB
    Zentralbl Veterinarmed B; 1997 Dec; 44(10):609-15. PubMed ID: 9467303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of vaccination route on the efficacy of Aujeszky's disease deletion-mutant vaccine.
    Hasebe H; Osorio FA; Hogg A; Liauw H; Bartkoski MJ; Sugiyama M
    J Vet Med Sci; 1992 Aug; 54(4):693-8. PubMed ID: 1327180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Field experiments to evaluate the feasibility of eradication of Aujeszky's disease virus by different vaccination schedules.
    De Smet K; De Waele K; Pensaert M; Goovaerts D; De Ridder E
    Vet Q; 1992 Jan; 14(1):22-8. PubMed ID: 1315465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies.
    van Oirschot JT
    Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Terpstra C; Moormann RJ; Berns AJ; Gielkens AL
    Vet Rec; 1990 Nov; 127(18):443-6. PubMed ID: 2177288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the protective efficacy of Aujeszky's disease (pseudorabies) virus glycoproteins obtained from different sources.
    Puentes E; Eiras A; Cancio E; Nores MV; Aguilera A; Seoane R; Regueiro BJ
    Vet Microbiol; 1993 May; 35(1-2):45-59. PubMed ID: 8395745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eradication of Aujeszky's disease virus from a Swedish pig herd using gI-/TK-vaccine.
    Engel M; Wierup M
    Vet Rec; 1997 May; 140(19):493-5. PubMed ID: 9172294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions.
    de Leeuw PW; van Oirschot JT
    Vet Q; 1985 Jul; 7(3):191-7. PubMed ID: 2996210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the immune response induced by intradermal vaccination by using a needle-less system in comparison with the intramuscular route in conventional pigs.
    Ferrari L; Borghetti P; Gozio S; De Angelis E; Ballotta L; Smeets J; Blanchaert A; Martelli P
    Res Vet Sci; 2011 Feb; 90(1):64-71. PubMed ID: 20546827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunogenicity of an inactivated culture vaccine against Aujeszky's disease].
    Aĭrapetian VG; Khachatrian AB; Chobanian MS
    Veterinariia; 1978 Mar; (3):56-8. PubMed ID: 205992
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vaccination in Aujeszky's disease on enzootic fattening farms].
    Motovski A; Veselinova A; Shalamanov D
    Vet Med Nauki; 1980; 17(4):23-9. PubMed ID: 6259802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Induction of biological protection in pigs against infection with Aujeszky disease virus by vaccination with large doses of live or inactivated vaccines].
    Zuffa A
    Vet Med (Praha); 1986 Feb; 31(2):83-94. PubMed ID: 3008403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trial of vaccination against Aujeszky's disease].
    Motovski A; Veselinova A; Dobrev V
    Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of different vaccination schedules for sows to protect piglets against Aujeszky's disease.
    Casal J; Planasdemunt L; Varo JA; Martín M
    J Vet Med B Infect Dis Vet Public Health; 2004 Feb; 51(1):8-11. PubMed ID: 14995971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of pigs against Aujeszky's disease by DNA vaccination.
    Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of mice against Aujeszky's disease virus infection by intranasal vaccination with inactivated virus.
    Takada A; Shimizu Y; Kida H
    J Vet Med Sci; 1994 Aug; 56(4):633-7. PubMed ID: 7999882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
    van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
    Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antibodies of field pseudorabies virus in pigs of herd vaccinated with live vaccine.
    Asai T; Tajima M; Watanabe H; Shibata I
    J Vet Med Sci; 1998 Mar; 60(3):399-400. PubMed ID: 9560796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.
    Mengeling WL; Brockmeier SL; Lager KM
    Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies.
    Kimman TG
    Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.